Economic value of exome sequencing for suspected monogenic disorders

A comment to this article is available online at https://doi.org/10.1038/s41436-020-0889-z. To the Editor: Schofield and colleagues recently published a cost-effectiveness analysis of exome sequencing (ES) as a replacement test for single- and multigene panel tests and other complex or invasive diagnostics for suspected monogenic disorders in infants aged 0–2 years.1.Schofield D. Rynehart L. Shresthra R. et al.Long-term economic impacts of exome...